Five sectors. Deep, not wide.

Player acquisition lives on Discord Quests, Reddit communities, TikTok, and YouTube pre-rolls, none of which translate literally. A Discord Quest needs gaming subculture fluency and internet slang, not a dictionary pass. The same discipline applies before a player ever sees an ad: a mistranslated keyword or screenshot caption in your App Store listing loses the install before the campaign starts.

The edge: we analyze regional gaming trends and map search intent around the local genres actually trending in that market, not the genre trending globally, then carry that same intent mapping into your localized App Store Optimization.

Retail and D2C brands burn budget fast on Meta, TikTok, and Google Shopping, refreshing creative weekly, which is exactly what the Generate-to-Deliver pipeline is built for.

The edge: we solve the full-funnel drop-off, not just the ad, transcreating the short-form hook and syncing the localized product feed to the localized landing page in the same pass.

Long buying journeys and high-intent search that can't be approximated: SaaS brands invest in Google SEM, developer-audience Reddit, and LinkedIn, and every technical term needs to land precisely for a buyer who's already comparing vendors.

The edge: intent mapping across the whole funnel, from high-intent search terms to localized case studies, so brand authority matches local buyer expectations at every stage.

Financial claims face the tightest ad-policy scrutiny on every platform, and a mistranslated interest rate, fee structure, or guarantee isn't just a bad ad, it's a regulatory problem. What counts as compliant also shifts market to market in ways a generalist campaign brief never accounts for.

The edge: every FinTech string runs through the same claim-density check the engine uses everywhere, tuned to flag financial claims specifically, so a human reviewer catches the problem before a regulator does.

Health and medical claims are among the most restricted ad categories on Google and Meta, and the rules diverge sharply by country: what clears as a factual claim in one market reads as an unsubstantiated medical claim in the next.

The edge: the same risk-routing discipline built for financial claims, applied to medical ones. This is a newer sector for us, and we're upfront about that, real compliance credibility here comes from having an in-market regulatory reviewer on a launch, not just the promise of one.